Newsroom

多伦多--(BUSINESS WIRE)--(美国商业资讯)-- SoluPet是一家以数据和科学为驱动的宠物认知健康公司，致力于为老年犬开发先进的认知老化支持方案。该公司今日宣 布与亚洲最大的上市医疗保健集团之一CHC达成战略合作。CHC拥有超过1,600名员工，业务涵盖医院、药房、兽用医疗器械和动物诊所。此次合作将通过直接面向消费者的试点项目，在台湾推广SoluPet的旗舰产品 Neuronal Defense ™。 此次合作标志着SoluPet首次进军亚太地区，也契合了全球对可靠、科学的犬类认知老化（CCA）解决方案日益增长的需求。台湾是全球第三大宠物护理市场，也是推出Neuronal Defense™等科学驱动型产品的理想首发市场。随着犬只寿命延长和宠物家庭数量的增加，CCA对全球老年宠物的影响日益加剧。Neuronal Defense™采用SoluPet独有的FDA GRAS（公认安全）活性成分配方，并有着十余年的数据驱动研究支持，体现了SoluPet致力于提升老年犬认知支持标准的承诺。 “与CHC的合作使SoluPet能够为宠物健康领域最紧迫的挑战之一——认知老化，提供科学...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - February 08.12.2025 GFEB.LN IE000X8M8M80  700,002.00 USD  25,775,985.90   36.823  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest S&P 500 Dividend Aristocrats Target Income UCITS ETF 08.12.2025 KNG.LN IE000SNMGYT5  200,002.00 USD   4,042,438.04   20.212  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - November 08.12.2025 GNOV LN IE000OJ31JQ4 1,300,002.00 USD  45,231,192.19   34.793  ...

ST. LOUIS--(BUSINESS WIRE)--Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, today announced the acquisition of Southwest Exterminating (Southwest) by PestCo Holdings, LLC (PestCo), a growth-oriented, national provider of pest control services to residential and commercial customers and a TSCP portfolio company. Based in Houston, TX, Southwest is a leading provider of commercial and residential pest control services in Texas. This acquisition represents a strat...

SAN FRANCISCO--(BUSINESS WIRE)--August Health, in partnership with the American Seniors Housing Association (ASHA), today released The Daily Realities of Clinical Care in Senior Living: The 2025 State of Senior Living Clinical Leadership Report, the second year of an ongoing effort to better understand the realities and priorities of clinical leadership across the senior living industry. This year's findings reveal the challenges of rising resident acuity and shifting staffing models as senior...

WASHINGTON--(BUSINESS WIRE)--Easterly Government Properties, Inc. (NYSE: DEA) (the “Company” or “Easterly”), a fully integrated real estate investment trust focused primarily on the acquisition, development and management of Class A commercial properties leased to the U.S. Government and its adjacent partners, announced today that management will participate in investor meetings at Nareit’s REITworld 2025 Annual Conference in Dallas, Texas on December 9 - 10, 2025. Electronic copies of the writ...

TYSONS, Va.--(BUSINESS WIRE)--Park Hotels & Resorts Inc. (“Park” or the “Company”) (NYSE:PK) today provided an update on its non-core disposition activity and fourth quarter operating trends. Non-Core Asset Disposition Update: Year-to-date, the Company has sold or entered into agreements or letters of intent to sell five Non-Core hotels for anticipated gross proceeds of approximately $198 million at an average multiple of nearly 43x. Closed transactions include the sale of the 316-room Hyat...

NEW YORK--(BUSINESS WIRE)--Academy Securities, the nation’s first Post-9/11 veteran owned and operated investment bank, today announced the addition of Elaine McCusker to its Advisory Board and Geopolitical Intelligence Group. Elaine McCusker joins Academy with over 30 years of defense and national security experience across the private sector, academia, and government service. She currently serves as a senior fellow at the American Enterprise Institute, where she publishes on defense strategy,...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced it has entered into an exclusive global collaboration and license agreement with YaoPharma, a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Limited (02196.HK and 600106.SH), a leading innovation-driven global healthcare company, for the development, manufacturing and commercialization of YP05002, a small molecule glucagon-like peptide 1 (GLP-1) receptor agonist currently in Phase 1 development for chronic weight manag...